![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215599
https://www.globenewswire.com/news-release/2021/06/09/2244357/0/en/InCarda-Therapeutics-Provides-Corporate-Update-Highlighting-New-Phase-2-Data-for-InRhythm-Program-Plans-for-Pivotal-Phase-3-Study-and-Expansion-of-Senior-Management-Team.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210683
http://www.prnewswire.com/news-releases/ani-pharmaceuticals-announces-launch-of-flecainide-tablets-300197290.html
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-usfda-nod-for-heart-rate-regulating-drug-flecainide-acetate/articleshow/48015181.cms?
http://www.fiercepharmaasia.com/story/idt-australia-release-fda-nod-23-generics-begs-question-wheres-beef/2015-04-14